LYMPHOMA RISK IN INFLAMMATORY BOWEL DISEASE PATIENTS TREATED WITH AZATHIOPRINE IN A DUTCH NATIONWIDE STUDY

(1) Gastroenterology and Hepatology, Leiden University Medical Center, Leiden

(2) Gastroenterology and Hepatology, Academic Medical Center, Amsterdam

(3) Gastroenterology, Radboud University Nijmegen Medical Center, Nijmegen

(4) Gastroenterology and Hepatology, University Medical Center Groningen, Groningen, Netherlands

(5) Gastroenterology and Hepatology, VU University Medical Center, Amsterdam

(6) Gastroenterology, University Hospital Maastricht, Maastricht

(7) Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam

(8) Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht, Netherlands



This item was part of the Safety and outcome prediction in IBD session at Gastro 2009 UEGW/WCOG London (17th UEGW)

This item can be cited as: Gut 2009; 58 (Suppl II) A34